# Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.

> **NCT00424567** · PHASE1,PHASE2 · TERMINATED · sponsor: **Vericel Corporation** · enrollment: 36 (—)

## Conditions studied

- Fracture, Ununited
- Pseudarthrosis

## Interventions

- **PROCEDURE:** Fracture surgery
- **DRUG:** Cultured Bone Marrow Tissue

## Key facts

- **NCT ID:** NCT00424567
- **Lead sponsor:** Vericel Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2003-10
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 36 (—)
- **Why stopped:** Closed early for business reasons (not safety reasons)
- **Last updated:** 2021-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00424567

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00424567, "Feasibility Study of Aastrom Tissue Repair Cells to Treat Non-Union Fractures.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00424567. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*